It is surprising that C-JUN outperforms other factors (ZAP70, LCK, IL-15, etc.)reported to promote CAR T function31–33,46,47 and can significantly promote CAR T therapeutic efficacy in AML disease model. The gene discussed is LCK; the disease is acute myeloid leukemia.